Clinical Trials on Haemophilia A Without Inhibitor
Total 843 results
-
Catalyst BiosciencesTerminatedFactor VII Deficiency | Hemophilia A With Inhibitor | Glanzmann ThrombastheniaUnited States, India, Italy, Russian Federation, Ukraine
-
Investigación en Hemofilia y FisioterapiaRecruiting
-
Novo Nordisk A/SAvailableCongenital HaemophiliaUnited States, Bulgaria, Sweden
-
Assistance Publique Hopitaux De MarseilleCompleted
-
Universidad Católica San Antonio de MurciaUnknown
-
CSL BehringRecruiting
-
Bio Products LaboratoryCompletedHaemophilia BUnited Kingdom, Poland
-
Bio Products LaboratoryCompletedHaemophilia BPoland, Romania, Russian Federation
-
University Hospital, BonnSwedish Orphan BiovitrumRecruiting
-
Assistance Publique Hopitaux De MarseilleCompleted
-
University of PretoriaNovo Nordisk A/S; Medical Research Council, South AfricaCompleted
-
Stowarzyszenie Pomocy Chorym na Zakrzepicę i Skazy...Unknown
-
Guy's and St Thomas' NHS Foundation TrustPfizerUnknownModerate and Severe Haemophilia
-
Assistance Publique - Hôpitaux de ParisUnknown
-
Novo Nordisk A/SActive, not recruiting
-
Universitaire Ziekenhuizen KU LeuvenCliniques universitaires Saint-Luc- Université Catholique de LouvainCompleted
-
Volkan Deniz, PTCompleted
-
University of ValenciaShireCompleted
-
Assistance Publique Hopitaux De MarseilleRecruiting
-
Prof. Dr. Dr. Thomas HilbergPfizerCompletedSports Physical Therapy | HaemophiliaGermany
-
Cliniques universitaires Saint-Luc- Université...World Federation of HemophiliaCompletedHaemophilia | Developing CountriesCôte D'Ivoire
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AUnited States, Netherlands, Spain, Switzerland, Taiwan, Turkey, United Kingdom, Croatia, Germany, Brazil, France, Japan, Australia, Hungary, Israel, Korea, Republic of, Lithuania, Portugal, Ukraine, Greece, Italy, Denmark, Norway, Canada and more
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AUnited States, Denmark, Austria, Spain, Japan, Brazil, Algeria, Lithuania, Portugal, Russian Federation, Serbia, Turkey, Greece, Hong Kong, Puerto Rico, Hungary, China, Poland
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AFrance, United States, Switzerland, Malaysia, Brazil, Canada, Japan, United Kingdom, Israel, Portugal, Ukraine, Greece, Lithuania, Puerto Rico, Turkey, Italy
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AFrance, United States, Denmark, Netherlands, Sweden, Spain, Germany, Switzerland, Taiwan, United Kingdom, Croatia, Malaysia, Brazil, Australia, Hungary, Israel, Turkey, Italy, Japan, Norway, Bulgaria
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AUnited States, Austria, Serbia, Germany, Japan, France
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AUnited States, Netherlands, Austria, Spain, Poland, United Kingdom, Croatia, Germany, Malaysia, Australia, France, Israel, Thailand, Ukraine, Turkey
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AUnited States, Macedonia, The Former Yugoslav Republic of, Serbia, Malaysia, Brazil, Turkey, Lithuania, Russian Federation, Italy, Japan, Poland, Puerto Rico, Taiwan
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AJapan
-
Real Fundación Victoria EugeniaUniversidad de Murcia; Medtep Inc.Unknown
-
Real Fundación Victoria EugeniaMedtep Inc.Unknown
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AMexico
-
Novo Nordisk A/STerminatedHealthy | Congenital Bleeding Disorder | Haemophilia AAustria, Spain, United Kingdom, France, Germany
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AAustria, Spain, United States, Germany, Serbia, Taiwan, Bulgaria
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AUnited States, Netherlands, Spain, Germany, France, Denmark
-
Universidad de MurciaUnknown
-
GWT-TUD GmbHHannover Medical School; Hoffmann-La RocheCompleted
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AJapan
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AItaly, Sweden, Netherlands, Austria, Spain, United States, Switzerland, Germany, France, Hungary, Greece, Slovenia, Czechia, Slovakia, Poland
-
Novo Nordisk A/SCompletedComparison of the Action of Drugs in the Body and Safety of N8 and Advate® in Haemophilia A SubjectsCongenital Bleeding Disorder | Haemophilia ASpain, Germany, Switzerland, Italy, Israel
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AUnited States, Germany, Switzerland, United Kingdom, Italy, Japan, Turkey
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia ASpain, Germany, Malaysia, Latvia
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AUnited Kingdom, Malaysia
-
Jazz PharmaceuticalsCompletedEvaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Known Inducer of CYP3A4 | Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Potent Inhibitor of CYP3A4 | Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a CYP2C19...United Kingdom
-
Universidad de MurciaCompleted
-
Hoffmann-La RocheActive, not recruitingSevere Hemophilia A | Moderate Hemophilia ABrazil, Germany, Italy, Spain, United States, Turkey, United Kingdom, Tunisia, Canada, Hungary, Morocco, Serbia
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AUnited States, Spain, Australia, France, Thailand, Italy, Malaysia, Austria, Greece, Japan, Taiwan, Canada, Israel, Algeria, Argentina, Bulgaria, Germany, Romania
-
Turkish Society of HematologyUnknown